Navigation Links
Hypothermia underutilized in cardiac arrest cases treated in US hospitals
Date:1/4/2012

New Rochelle, NY -- Therapeutic hypothermia has been proven to reduce mortality and improve neurologic outcomes after a heart attack, yet it was rarely used in a sample of more than 26,000 patients, according to a study published in Therapeutic Hypothermia and Temperature Management, a peer-reviewed journal published by Mary Ann Liebert, Inc. The article is available at www.liebertpub.com/ther

Therapeutic hyperthermia was used in only 0.35% of cases of out-of-hospital cardiac arrest in this study. The authors, Pratik Patel, Sayona John, Rajeev Garg, Richard Temes, Thomas Bleck, and Shyam Prabhakaran, from Rush University Medical Center, Chicago, IL, state that "Continued education, dissemination of evidence-based guidelines to community hospitals, the development of and preferential transport of patients to designated cardiac arrest treatment centers, and enhanced reimbursement may help increase its application in clinical practice." The article is entitled "Therapeutic Hypothermia After Cardiac Arrest is Underutilized in the United States." (http://www.liebertonline.com/doi/pdfplus/10.1089/ther.2011.0015)

"This informative study underscores the need to more efficiently target and treat cardiac arrest patients that would benefit from hypothermic therapy. The fact that therapeutic hypothermia is underutilized at U.S. hospitals emphasizes the need to identify and address barriers to this evidence-based therapy," says W. Dalton Dietrich, PhD, Editor-in-Chief of the Journal and Kinetic Concepts Distinguished Chair in Neurosurgery, Professor of Neurological Surgery, Neurology and Cell Biology and Anatomy, University of Miami Leonard M. Miller School of Medicine.


'/>"/>
Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Page: 1

Related biology news :

1. New findings on therapeutic hypothermia following cardiac arrest in children
2. Stevens biomedical engineering students fight hypothermia on the battlefield
3. Hypothermia proven to improve survival and outcomes following out-of-hospital cardiac arrest
4. Therapeutic Hypothermia journal launching in spring 2011
5. Suspended animation protects against lethal hypothermia, study shows
6. Therapeutic hypothermia is promising strategy to minimize tissue damage
7. Genetic testing for breast or ovarian cancer risk may be greatly underutilized
8. Geoscientists find key to why some patients get infections from cardiac implants
9. Adrenaline use in cardiac arrest
10. Johns Hopkins researchers identify new genetic risk factor for sudden cardiac death
11. Outcomes for cardiac valve procedure patients are affected by insurance status
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hypothermia underutilized in cardiac arrest cases treated in US hospitals
(Date:7/21/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market and ... it has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology ... but also the user using unique personal identifiers ...
(Date:7/13/2015)... Conn. , Jul. 13, 2015 NXT-ID, ... "Company"), a biometric authentication company focused on the ... has filed provisional patent 62/188684 for ... achieves another new convenient and secure method to ... new, innovative payment methods, introduced with its groundbreaking ...
(Date:7/9/2015)... JOSE, Calif. , July 9, 2015 ... the leading developer of human interface solutions, ... technology, the industry,s first fully hardware encapsulated ... Match-in-Sensor secure authentication technology is literally off ... storage and biometric matching within the fingerprint ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3
... a world-leading provider of scientific, technical and medical information ... for Parasitology, is pleased to announce the launch of ... and Wildlife . The new electronic open access ... International Journal for Parasitology , and will address ...
... 2012 National data indicate that milk consumption has ... low nutritional quality has more than doubled. Although this ... drinks in children,s diets, a new study suggests that ... significantly related to changes in their consumption of sodas ...
... Western University in London, Canada and the Children,s Health ... Institute, have identified the critical role of a receptor ... beta cells, making it an exciting therapeutic target for ... by Rennian Wang, demonstrated that overexpression of c-Kit not ...
Cached Biology News:Elsevier launches International Journal for Parasitology: Parasites and Wildlife 2Sugar-sweetened drinks are not replacing milk in kid's diets 2Sugar-sweetened drinks are not replacing milk in kid's diets 3A 'Kit' for increasing insulin production 2
(Date:8/3/2015)... Ga. , Aug. 3, 2015  MiMedx Group, ... company utilizing human amniotic tissue and patent-protected processes to ... Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and ... present at the 35 th Annual Canaccord|Genuity Growth ... H. "Pete" Petit, Chairman and CEO, William C. ...
(Date:8/3/2015)... 2015  Merck KGaA, Darmstadt, Germany ... products in the healthcare, life science and performance materials ... their development and launch of promising new fullerene derivatives ... KGaA, Darmstadt, Germany , is pursuing ... Novel derivatives: highly stable, easy to process ...
(Date:8/3/2015)... Medical, Inc. (Nasdaq: AEMD ), the pioneer in ... announced that it will host its First Quarter Fiscal ... 13, 2015 at 4:30 p.m. Eastern Time. ... fiscal 2016 first quarter results.  A recorded version of ... the call at the Investor Relations portion of the ...
(Date:8/3/2015)... Aug. 3, 2015   Intrexon Corporation (NYSE: ... half and second quarter 2015 financial results after the ... The Company will host a conference call at 5:30 ... general business update. The conference call may ... (International), and asking to join the "Intrexon Corporation Call."  ...
Breaking Biology Technology:MiMedx To Present At 35th Annual Canaccord|Genuity Growth Conference 2Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 2Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 3Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 4Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015 2Intrexon to Announce First Half and Second Quarter 2015 Financial Results and Host Conference Call on August 10th 2
... MS, EDMONTON, Oct. 6 /PRNewswire-FirstCall/ - BioMS ... treatment of multiple sclerosis (MS), today,announced that the ... phase II MINDSET-01 trial of dirucotide (MBP8298) in ... and recommended,that the trial continue as per the ...
... from years of, study by leading research scientists in Russia, ... ... Colo., Oct. 6 On Thursday, October 16, 2008 at,the EUPROBIO 2008 ... on cytotoxicity of,natural killer cells" will be presented to physicians, researchers and,educators. ...
... BOSTON, Oct. 6 PAREXEL International,Corporation (Nasdaq: ... at the,William Blair Small-Cap Growth Stock Conference in ... Chief Financial Officer will be making,a formal presentation ... October 7,2008., A live webcast of this ...
Cached Biology Technology:BioMS Medical's relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board 2EUPROBIO 2008 Presentation to Highlight Latest Immune Research 2PAREXEL International to Present at William Blair Small-Cap Growth Stock Conference 2
Ezrin/Radixin/Moesin Antibody...
Rabbit Anti-conjugated Agmatine Polyclonal Antibody...
ABCA1 Immunogen: Mouse ABCA1-expressing HeLa stable transfectants. Storage: -20 C, Avoid Freeze/Thaw Cycles...
... ( Abpromise for all tested ... Synthetic peptide based on the propeptide ... amino acid sequence is proprietary) ... SWISS Protein ID: ...
Biology Products: